p19 ARF Inhibitors

Common p19 ARF Inhibitors include, but are not limited to Nutlin-3 CAS 548472-68-0, PRIMA-1MET CAS 5291-32-7, Tenovin-6 CAS 1011557-82-6, JNJ 26854165 CAS 881202-45-5 and Nutlin-3 CAS 548472-68-0.

P19 ARF inhibitors form a distinctive category of compounds designed to interact with and regulate the function of p19 ARF, also known as CDKN2A or alternate reading frame protein. P19 ARF is a protein encoded by the CDKN2A gene and is a crucial component in the intricate machinery that controls cell cycle progression and cellular responses to stress. It is primarily known for its role as a tumor suppressor, as it can induce cell cycle arrest and inhibit cell growth, acting as a guardian against uncontrolled proliferation.

These inhibitors are meticulously tailored to target specific binding sites within the p19 ARF protein, aiming to modulate its functional activity. By engaging with p19 ARF, these inhibitors influence its interaction with other cellular components, including its association with MDM2 and p53, thereby impacting cell cycle regulation and apoptotic pathways. The exploration of p19 ARF inhibitors is driven by the aim to unravel the intricate molecular mechanisms through which p19 ARF orchestrates its tumor suppressor functions and contributes to cellular homeostasis. Through the study of these inhibitors, researchers gain insights into the fundamental processes governing cell cycle control and the delicate balance between cell growth and cell death, shedding light on the complex network of interactions that underlie cellular behavior and response to stress.